key: cord-0998466-8h819gtu authors: Weinberger, Tobias; Steffen, Julius; Osterman, Andreas; Mueller, Tonina T; Muenchhoff, Maximilian; Wratil, Paul R; Graf, Alexander; Krebs, Stefan; Quartucci, Carolina; Spaeth, Patricia M; Grabein, Beatrice; Adorjan, Kristina; Blum, Helmut; Keppler, Oliver T; Klein, Matthias title: Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany date: 2021-01-03 journal: Clin Infect Dis DOI: 10.1093/cid/ciaa1935 sha: 5180db52d0ad3994812c25b64f292754938689db doc_id: 998466 cord_uid: 8h819gtu BACKGROUND: High infection rates among health care personnel in an uncontained pandemic can paralyze health systems due to staff shortages. Risk constellations and rates of seroconversion for health care workers during the first wave of the SARS-CoV-2 pandemic are still largely unclear. METHODS: Health care personnel (n=300) on different organizational units in the LMU Munich University Hospital were included and followed in this prospective longitudinal study in the period of March 24 until July 7, 2020. Participants were monitored in intervals of two to six weeks using different antibody assays for serological testing and questionnaires to evaluate risk contacts. In a subgroup of infected participants, we obtained nasopharyngeal swabs to perform whole genome sequencing for outbreak characterization. RESULTS: Health care workers involved in patient care on dedicated COVID-19 wards or on regular non-COVID-19 wards showed a higher rate of SARS-CoV-2 seroconversion compared to staff in the emergency department and non-frontline personnel. The landscape of risk contacts in these units was dynamic, with a decrease of unprotected risk contacts in the emergency department and an increase on non-COVID-19 wards. Both, the intensity and number of risk contacts, were associated with higher rates of seroconversion. On regular wards, staff infections tended to occur in clusters, while infections on COVID-19 wards were less frequent and apparently independent of each other. CONCLUSION: The risk of SARS-CoV-2 infection for front-line health care workers was increased during the first pandemic wave in Southern Germany. Stringent measures for infection control are essential to protect all patient-facing staff during the ongoing pandemic. The Coronavirus disease pandemic caused by the SARS coronavirus 2 (SARS-CoV-2) has brought health care systems all over the globe on the brink of collapse. The spread of SARS-CoV-2 has led to over 54 million infections worldwide and caused the death of over 1.2 million patients [1] . High patient numbers and the high contagiousness of SARS-CoV-2 [2] overwhelmed health care systems and put front-line health care workers (HCWs) at risk of infection: A case series performed in China during the early phase of the pandemic showed that 29% of infected patients were HCWs who were assumed to have acquired the infection at work [3] . A study comparing the general population with front-line HCWs in the UK and the US reported a significantly increased risk of SARS-CoV-2 infections among HCWs [4] . Besides the individual health risk, increasing rates of COVID-19 among HCWs may rapidly result in a bottleneck in patient care with detrimental effects on health care systems, already stretched to the limit under normal, non-pandemic circumstances [5, 6] . Of particular note, not only symptomatic patients, but also pre-or asymptomatic infected individuals can spread SARS-CoV-2 efficiently [7] , potentially leading to patients with undiagnosed SARS-CoV-2 infections to act as sources of ongoing transmissions [8] . Similarly, HCWs with asymptomatic infections may increase the risk of nosocomial infections [9] , which might be particularly harmful to the elderly and patients at risk for severe COVID-19 [10] . Therefore, protection of HCWs from contracting or spreading a SARS-CoV-2 infection represents an important goal to stabilize health care systems in a pandemic, creating an urgent need to determine which HCWs are at particular infection risk and how they got infected. We hypothesized, that high frequency and intensity of contacts to infected patients on COVID-19 wards would result in more HCW infections reflected by higher frequencies of SARS-CoV-2 seroconversion compared with HCWs on non-COVID-19 wards or those who were not involved in patient-facing care. A c c e p t e d M a n u s c r i p t To unravel the rate of seroconversion among HCWs in different clinical functions, we performed a longitudinal seroconversion survey in the LMU Munich University Hospital. In four consecutive visits from March 24 until July 7, 2020, covering the complete first wave of the pandemic in Southern Germany, we analyzed risk contacts, rate of seroconversion, and employed whole genome virus sequencing for cluster analysis of perceived outbreaks in a subgroup of HCWs. The LMU Munich University Hospital is a large quaternary care hospital in Munich, Germany (approximately 2000 beds, more than 10000 employees). Enrolment was performed on prespecified organizational units: 1 st ) Non-frontline HCWs (NF-HCWs), 2 nd ) Emergency Department (ED-HCWs), 3 rd ) Intensive Care and General Wards specifically dedicated to care for non-COVID-19 (non-COVID-HCWs) and 4 th ) for COVID-19 patients (COVID-HCWs) ( Figure 1 ). Participation in the study was voluntarily. After written consent was obtained by the participant, four visits were performed, each consisting of a blood collection (7.5 ml) and a questionnaire (Figure 1 and 2) . Study participant data were collected and pseudonymized for measurements. For virus genome analysis, participants with a RT-PCR-confirmed infection were asked to contact the study team to obtain a swab sample for phylogenic analysis. Data from patients were used in an anonymized fashion. The study was approved by the ethical committee of the Medical Faculty of the Ludwig-Maximilians-University (No: 20-247 and No: 20-245). Visits were performed from March 24th to July 7 th , starting only few days after the first lockdown decision issued by the responsible authorities on March 21 st , 2020 ( Figure 2 ). Organizational measures taken by the hospital in order to prevent disease spread among patients and personnel are depicted in Figure 2 . A c c e p t e d M a n u s c r i p t Personal protective equipment (PPE) was provided to every staff member and included daily supplies of surgical face masks. Care of patients with either suspected or PCR-proven SARS-CoV-2 infection was performed with PPE according to the local hygiene recommendations including eye protection (shield or goggles), filtering face piece (FFP) 2 masks and disposable protective clothing (coats and gloves). Re-use of PPE was strongly discouraged. Videos and posters to educate HCWs to correctly perform donning and doffing were distributed among all HCWs. The questionnaire addressed demographic data, medical history, PCR testing for SARS-CoV-2, area of patient care, profession, contact to SARS-CoV-2 infected subjects (patients, colleagues, or private contacts), and intensity of contacts according to the classification of the Robert Koch Institute [11] . Risk categories were self-assessed by the participants using a flow chart (Supplementary File 1). Briefly, contact category 1 was defined as a close contact to an infected patient, colleague, or private person, i.e. less than 2 meters apart for more than 15 minutes, or as contact to potentially infectious aerosols or contaminated fluids (e.g. during intubation) while not wearing PPE. Contact category 2 was defined as an unprotected contact to an infected person (either patient, colleague or private person) who did not fulfill all of the above-mentioned criteria (e.g. a contact under 15 minutes with less than two meters distance or a contact over 15 minutes but with over two meters distance). Category 3 only applied to contacts with positive tested patients and co-workers in the hospital when protection measures (FFP2 mask, protective gown, glasses, gloves) were in worn. Available samples from visits 1-4 were screened using Anti-SARS-CoV-2 IgG and IgA (EuroImmun, Lübeck, Germany) and Elecsys® Anti-SARS-CoV-2 Ig (Roche, Basel, Switzerland) assays. Subsequently, all samples of volunteers with at least one positive A c c e p t e d M a n u s c r i p t screening result were tested with LIAISON® SARS-CoV-2 S1/S2 IgG (DiaSorin, Saluggia, Italy) and ARCHITECT SARS-CoV-2 IgG assay (Abbott, Chicago, USA) assays. Seroconversion was defined as seronegativity at visit 1 and at least two IgG/total Igdetecting test systems showing reactivity in subsequent visits. In case of low level anti-SARS CoV-2 antibodies at visit 1, a significant increase in antibody titer in at least two test systems at subsequent visits was also considered as seroconversion. All commercial serological tests were performed according to manufacturers' instructions. In a subgroup of study participants with PCR-confirmed SARS-CoV-2 infection, we obtained nasopharyngeal swabs for phylogenic analysis. Amplicon pools spanning the SARS-CoV-2 genome were prepared for each sample, converted to barcoded sequencing libraries and sequenced on a MinION R9.4.1 flowcell following the ARTIC network nCoV-2019 sequencing protocol v2 (dx.doi.org/10.17504/protocols.io.bdp7i5rn). The sequenced amplicons were assembled using the Artic bioinformatics protocol (http://artic.network/ncov-2019). Phylogenetic analyses were achieved with the web-and analysis platform Auspice using the SARS-CoV-2 build (https://github.com/nextstrain/ncov) and the bioinformatic toolkit augur (https://github.com/nextstrain/augur). The consensus sequences and meta data for the samples were uploaded to the GISAID repository. Categorical variables were compared between groups using the Pearson's Chi-squared or We enrolled 338 of 362 invited employees at two sites of LMU Munich University Hospital between March 24th and April 2nd on pre-specified organizational units as described above. 38 subjects were excluded from the study, including 2 HCWs already seroconverted for SARS-CoV-2 at visit 1. The final analysis included 300 subjects (41 non-frontline (NF) HCWs, 29 Emergency-Department (ED) HCWs, 90 non-COVID-HCWs, and 140 COVID-HCWs) ( Figure 2 ). Gender, medical history, or medication did not differ significantly between the four groups, except NF-HCWs were significantly older compared to the other groups ( Table 1) . A c c e p t e d M a n u s c r i p t Taken together, we found an increased rate of seroconversion in HCWs facing patients on hospital wards in general, which was even more pronounced in the subgroup of HCWs treating patients without suspected SARS-CoV-2 infection. Remarkably, none of the HCWs in the ED, regularly providing the initial care for patients with SARS-CoV-2 infection, seroconverted in our study. To decipher the role of contacts with SARS-CoV-2-infected subjects in a hospital setting, we analyzed the risk contacts of HCWs to infected patients, colleagues and in their private environment. We found an increased rate of seroconversion among participants, who had reported at least one contact to an infected person. This rate increased with the category of the risk contact reported. Odds ratios (OR) for seroconversion for class 1 (unprotected) and class 2 (unprotected, but less intense) contacts were 3.61 ([95% confidence interval (CI), Figure 6A ). In contrast, non-COVID-HCWs reported a marked increase of risk contacts over the study period, mainly driven by unprotected contacts to colleagues or patients ( Figure 6B-D) . HCWs caring for COVID-19 patients reported a substantial, yet stable rate of unprotected contacts during the study period ( Figure 6A) . Previously, whole virus genome sequencing has been reported to help unravel unknown routes of hospital-acquired infections [12] . In our study, SARS-CoV-2 RNA for genome sequencing was available from nasopharyngeal swabs of four HCWs with RT-PCRconfirmed infection (Figure 7A) . Phylogenetic analyses found that three samples obtained in the second period represented a cluster of nosocomial infections, starting from an initially undiagnosed infected patient, who was treated for a COVID-19-unrelated disease on a regular ward (patient 0) ( Figure 7B) . Two of the seropositive HCWs worked on the ward where patient 0 was treated. Another HCW who got infected in this cluster had been visiting a hospitalized relative ( Figure 7C ). This prospective longitudinal serological analysis provides detailed information on risk exposure to SARS-CoV-2 and seroconversion rates of HCWs of different organizational units during the first wave of the pandemic in Munich, Germany. We report that frontline HCWs are at an increased risk of infection compared to non-frontline HCWs, who have been reported to show a similar risk of infection as the general public [13] . Unprotected contact to an infected person was associated with a higher rate of seroconversion. The seroconversion rate was not only influenced by the degree but also by the frequency of reported risk contacts. Surprisingly, non-COVID-HCWs showed a higher rate of unprotected exposure to A c c e p t e d M a n u s c r i p t SARS-CoV-2-infected patients compared to COVID-HCWs. The higher rate of seroconversion in HCWs caring for patients initially classified as "non-COVID-19" seemed to be mainly influenced by the two infection clusters. We found that unprotected risk contacts shifted from the ED to non-COVID-19 wards with progression of the first pandemic wave. This may, at least partly, be explained by the occurrence of clusters of infections on non-COVID-19 wards and the stringent use of PPE in the ED and on COVID-19 wards. While private risk contacts showed an association with seroconversion similar to occupational contacts, these contacts were infrequent compared to contacts at work, underlining the HCWs (24-fold) [4] . Furthermore, patients with a false-negative PCR-test and no obvious clinical COVID-19-related symptoms, can spread the infection in the hospital [14, 15] . A decrease of protective measures in these patients after admission to the hospital might represent a "trojan-horse" effect, adding to the observed increase of risk contacts on normal wards during the first pandemic wave. In line with our results, previous seroprevalence studies have reported an increased frequency of seroconversion not only among COVID-HCWs but also among HCWs caring A c c e p t e d M a n u s c r i p t for non-COVID-19 patients [13, 16] . However, there is controversial data on the risk differences of HCWs in specific areas. Some studies show an increase risk for COVID-HCWs [13, 16, 17] , while others did not find relevant differences in risk compared to HCWs on regular wards [18, 19] . Another study reported a reduced risk for HCWs on intensive care units compared to regulars wards, all providing providing care for COVID-19 patients [20] . One explanation for the increased risk for seroconversion in non-COVID-HCWs in our study might be the occurrence of two infection clusters. Only sporadic infections were observed in COVID-HCWs. Further, reuse or inappropriate use of PPE has been reported to be associated with an increased SARS-CoV-2 infection risk [4] . Reuse of PPE was strongly discouraged in our hospital and sufficient PPE was available for all HCWs at all times. This may explain the relatively small number of seroconverted HCWs on COVID-19 wards compared to other studies, where, especially at the beginning of the pandemic, a shortage of PPE made the reuse of protective equipment more common [13] . To the best of our knowledge, this is the first study reporting prospective and longitudinal data on seroconversion of HCWs covering the complete first pandemic wave of COVID-19. Most of the available studies are based on self-reporting [13] data or are of retrospective nature [13, 16, [21] [22] [23] [24] . Our study also has limitations. Due to the novelty of the disease, there were only limited study resources available, resulting in a small number of HCWs included in this study. M a n u s c r i p t Study flow chart illustrating the recruitment process and the study samples analyzed. After invitation, 338 HCWs from COVID-19 wards, from non-COVID-19 wards, from the hospital's emergency departments as well as non-frontline HCW were recruited to the study. 36 participants were excluded due to withdrawal of consent (n=6), terminated work contracts (n=15) or other reasons (n=4). In total, seven participants were lost to follow up. 302 samples underwent serologic testing. Due to seropositivity at the start of the study, two participants were excluded before data analysis. Participants were stratified for working area. 47% (n=140) of participants were working on wards with contact to COVID-19 patients, 30% (n=90) of participants were working on wards without COVID-19 patients. 10% (n=29) of participants were part of the emergency room team with potential contact to COVID-19 patients (ED HCW). 41 participants (14%) were non-frontline HCWs. COVID-19 Map -Johns Hopkins Coronavirus Resource Center Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics Clinical Characteristics of 138 Hospitalized Patients With Novel Coronavirus-Infected Pneumonia in Wuhan, China Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study The impending storm: COVID-19, pandemics and our overwhelmed emergency departments COVID-19 and Italy: what next? Lancet, 2020 Temporal dynamics in viral shedding and transmissibility of COVID-19 Protecting health-care workers from subclinical coronavirus infection Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital Serology-informed estimates of SARS-CoV-2 infection fatality risk in RKI -Coronavirus SARS-CoV-2 -Kontaktpersonen-Nachverfolgung bei Infektionen durch SARS-CoV-2. Available from: www.rki.de/covid-19 Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure Viral dynamics in asymptomatic patients with COVID-19 Risk of COVID-19 in health-care workers in Denmark: an observational cohort study Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study Prevalence of COVID-19 Infection and Outcomes Among Symptomatic Healthcare Workers in SARS-CoV-2 infection among healthcare workers in a hospital in Madrid Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic COVID-19) Infections Among Healthcare Workers SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients We would like to thank Elisabeth Foitzik and Burak Karakoc for technical assistance.Further, we thank all CORKUM investigators and staff. We also thank the patients and their families for their participation in the CORKUM registry. This research project/publication was supported by LMUexcellent, funded by the Federal Ministry of Education and Research (BMBF) and the Free State of Bavaria under the Excellence Strategy of the Federal Government as well as the "Stiftungen zugunsten der Medizinischen Fakultät -Cluster: 2". The study was funded in part by the BMBF initiative "NaFoUniMedCovid19" (01KX2021), subproject B-FAST. The authors declare no competing interests. Arcgis.com. Available from:https://www.arcgis.com/home/item.html?id=f10774f1c63e40168479a1feb6c7ca74.